Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02734849 · ClinicalTrials.gov registry record · Phase 2
Study to Evaluate Multiple Doses in Patients With Nasal Polyposis
A Phase 2 study, sponsored by Allakos.
- Completed
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
NCT02734849 is a Phase 2 study that has completed, run by Allakos. The registered enrollment target is 40 participants.
The verdict
NCT02734849, a Phase 2 study, has completed, sponsored by Allakos.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
Study Summary
This is a phase 2 study to evaluate multiple doses of AK001 across 2 active doses. Pharmacodynamic activity will also be evaluated.
Interventions
- DRUG Placebo
- DRUG AK001 low dose
- DRUG AK001 high dose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2016-04 |
| Est. Completion | 2018-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02734849
The ClinicalTrials.gov registry entry for NCT02734849 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allakos, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT02734849 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02734849 about?
NCT02734849 is a clinical study titled "Study to Evaluate Multiple Doses in Patients With Nasal Polyposis". This is a phase 2 study to evaluate multiple doses of AK001 across 2 active doses. Pharmacodynamic activity will also be evaluated.
What is the current status of trial NCT02734849?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2016-04. Estimated completion is 2018-01.
What interventions are being tested in trial NCT02734849?
The interventions under investigation include: Placebo (DRUG), AK001 low dose (DRUG), AK001 high dose (DRUG).
Who is sponsoring clinical trial NCT02734849?
This trial is sponsored by Allakos, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.